622207-5cb01321-dbd8-44a0-b778-73f4c34f1a47
Position
President
Company
FACIT
Location
Toronto Ontario CANADA
Bio
Dr. David O’Neill brings extensive experience in Pharma, Biotech and seed stage investing to his role as President of FACIT. Dr. O’Neill has a wealth of networks and transaction experience through various business development roles at AstraZeneca, Ambit Biosciences (Daiichi Sankyo), Kinomescan (Discoverx/Eurofins), Fluorinov Pharma (Trillium Therapeutics). He also held operational roles including non-clinical safety, IND submission and Project Leader during clinical development of Quizartinib. He has provided interim executive management to FACIT spin outs Turnstone Biologics and Propellon Therapeutics. In addition to serving on the Board of Turnstone and Triphase Accelerator, he is also a Board Observer for Fusion Pharmaceuticals. Dr. O’Neill holds a PhD from Western University from the Faculty of Health Sciences.
Interests
None yet.